Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology
Health Expectations · 2024
DOI: 10.1111/hex.14068 ↗At a glance
Journal article in Health Expectations, 2024. Written by Nils Graber and 9 co-authors. Institution: Institute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerla…. Major MEDLINE topics: Medical Oncology, Research Design. Cited 2 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY 4.0). Funded by: ISREC Foundation, Swiss Cancer Research Foundation.
Abstract (original language)
Background
Experience‐Based Co‐Design (EBCD) is a multi‐stage participatory action research process which was developed originally to increase patient involvement in service improvement initiatives. This viewpoint article serves as a reflection on the researchers' experiences, focusing on the application and feasibility of participatory approaches, particularly co‐design, in the specific context of early‐phase clinical trials.
Methods
We reflect on the opportunities and challenges of applying EBCD in a new context of early‐phase clinical trials in oncology where experimental treatments are increasingly perceived as a therapeutic option and, in certain instances, their efficacy may lead to accelerated approval facilitating a swifter integration into standard care.
Results
We propose that the opportunity of applying EBCD in such trials lies in improving the delivery of person‐centered care, care coordination, and support during the transition from experimental to standard care. Three potential challenges when applying EBCD in early‐phase clinical trials are discussed related to: the need for standardization in trial processes; planning EBCD in a context of high uncertainty; and vulnerability of patient populations.
Conclusion
Integrating EBCD into early‐phase oncology trials presents an opportunity to enhance person‐centered care and can lead to simultaneous improvements in care processes and therapeutic development. Patient or Public Contribution This article has been developed with the collaboration of a patient partner who serves on the advisory board of our ongoing EBCD study in early clinical trials.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Institute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.
- School of Nursing and Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
- Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
- Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
ORCID profiles: Glenn Robert, Sara Colomer-Lahiguera
Funding
- ISREC Foundation
- Swiss Cancer Research Foundation
Cite
APA
Graber, N., Canova, N., Bryant-Lukosius, D., Robert, G., Navarro-Rodrigo, B., Trueb, L., Coukos, G., Eicher, M., Corbière, T., & Colomer-Lahiguera, S. (2024). Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology. Health Expectations. https://doi.org/10.1111/hex.14068
Vancouver
Graber N, Canova N, Bryant-Lukosius D, Robert G, Navarro-Rodrigo B, Trueb L, et al. Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology. Health Expectations. 2024. doi:10.1111/hex.14068
BibTeX
@article{Graber2024,
author = {Graber, Nils and Canova, Nina and Bryant-Lukosius, Denise and Robert, Glenn and Navarro-Rodrigo, Blanca and Trueb, Lionel and Coukos, George and Eicher, Manuela and Corbière, Tourane and Colomer-Lahiguera, Sara},
title = {Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology},
journal = {Health Expectations},
year = {2024},
doi = {10.1111/hex.14068}
}
EUVIMED